Bone Grafts Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Grafts, including details on spine fusion, surgery, procedure, risks.

Volume 6 (2009), Issue 5 (May)

1. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
   Blood, 113(18): 4458-67. [Abstract] [Full-text]
2. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.
   J Am Soc Nephrol, 20(5): 1053-67. [Abstract] [Full-text]
3. Partial Reconstitution of Cutaneous Microvessels in Long-Term Survivors after Allogeneic Bone Marrow Transplantation.
   Dermatology. [Abstract] [Full-text]
4. Experimental results of combining bisphosphonates with allograft in a rat model.
   J Bone Joint Surg Br, 91(5): 670-5. [Abstract] [Full-text]
5. Periodontal biotype influence on the volume maintenance of onlay grafts.
   J Periodontol, 80(5): 816-23. [Abstract] [Full-text]
6. Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.
   Haematologica, 94(5): 654-62. [Abstract] [Full-text]
7. Surgical management of the symptomatic unstable sternum with pectoralis major muscle flaps.
   Plast Reconstr Surg, 123(5): 1495-8. [Abstract] [Full-text]
8. Immediate versus delayed one-stage sternal débridement and pectoralis muscle flap reconstruction of deep sternal wound infections.
   Plast Reconstr Surg, 123(5): 1490-4. [Abstract] [Full-text]
9. Articular cartilage tissue engineering: today's research, tomorrow's practice?
   J Bone Joint Surg Br, 91(5): 565-76. [Abstract] [Full-text]
10. Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.
    Blood, 113(18): 4331-40. [Abstract] [Full-text]
11. Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.
    Int Immunopharmacol, 9(6): 694-700. [Abstract] [Full-text]
12. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Am J Hematol, 84(5): 283-6. [Abstract] [Full-text]
13. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    J Cell Physiol, 220(1): 16-20. [Abstract] [Full-text]
14. Umbilical cord stem cell transplantation.
    Semin Oncol Nurs, 25(2): 115-9. [Abstract] [Full-text]
15. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).
    Prog Cardiovasc Dis, 51(6): 524-39. [Abstract] [Full-text]
16. Reactivation of hepatitis B.
    Hepatology, 49(5): S156-65. [Abstract] [Full-text]
17. Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion.
    Am J Hematol, 84(5): 295-7. [Abstract] [Full-text]
18. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
    J Bone Joint Surg Am, 91(5): 1199-206. [Abstract] [Full-text]
19. Humeral head arthroplasty and meniscal allograft resurfacing of the glenoid.
    J Bone Joint Surg Am, 91(5): 1109-19. [Abstract] [Full-text]
20. Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside.
    J Bone Joint Surg Am, 91(5): 1073-83. [Abstract] [Full-text]
21. Novel pathogenic insights in the primary prevention of cardiovascular disease.
    Prog Cardiovasc Dis, 51(6): 503-23. [Abstract] [Full-text]
22. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
    J Clin Invest, 119(5): 1136-49. [Abstract] [Full-text]
23. Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures.
    Leuk Res, 33(7): 997-1000. [Abstract] [Full-text]
24. Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: a randomized prospective study.
    Eur Spine J, 18(5): 687-95. [Abstract] [Full-text]
25. In vivo testing of nanoparticle-treated TTCP/DCPA-based ceramic surfaces.
    Acta Biomater, 5(5): 1767-74. [Abstract] [Full-text]
26. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    J Immunol, 182(10): 5970-81. [Abstract] [Full-text]
27. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia.
    J Immunol, 182(10): 5938-48. [Abstract] [Full-text]
28. Pre-operative irreducible C1-C2 dislocations: intra-operative reduction and posterior fixation. The "always posterior strategy".
    Acta Neurochir (Wien), 151(5): 551-9; discussion 560. [Abstract] [Full-text]
29. Comparison of in vitro and in vivo bioactivity of SrO-CaO-ZnO-SiO2 glass grafts.
    J Biomater Appl, 23(6): 561-72. [Abstract] [Full-text]
30. Bistable switches control memory and plasticity in cellular differentiation.
    Proc Natl Acad Sci U S A, 106(16): 6638-43. [Abstract] [Full-text]
31. Donor sites for pedicled skeletal grafts of the hand, wrist, and forearm.
    Microsurgery. [Abstract] [Full-text]
32. Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts.
    Acta Pharmacol Sin, 30(5): 530-6. [Abstract] [Full-text]
33. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
    J Natl Cancer Inst, 101(9): 663-77. [Abstract] [Full-text]
34. A comparative study of the physical and mechanical properties of three natural corals based on the criteria for bone-tissue engineering scaffolds.
    J Mater Sci Mater Med, 20(6): 1273-80. [Abstract] [Full-text]
35. Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism.
    Bone Marrow Transplant. [Abstract] [Full-text]
36. Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.
    Bone Marrow Transplant. [Abstract] [Full-text]
37. Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis.
    Bone Marrow Transplant. [Abstract] [Full-text]
38. Early lymphocyte recovery after allogeneic hematopoietic SCT is associated with significant GVL effect in pediatric ALL but not acute myelogenous leukemia-Update study.
    Bone Marrow Transplant. [Abstract] [Full-text]
39. Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction.
    Bone Marrow Transplant. [Abstract] [Full-text]
40. Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
    Bone Marrow Transplant. [Abstract] [Full-text]
41. Approach to the patient with transplantation-related bone loss.
    J Clin Endocrinol Metab, 94(5): 1483-90. [Abstract] [Full-text]
42. Conventional wisdom and the surgical exposure of impacted teeth.
    Orthod Craniofac Res, 12(2): 82-93. [Abstract] [Full-text]
43. Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors.
    Blood, 113(19): 4790-8. [Abstract] [Full-text]
44. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
    Blood, 113(19): 4780-9. [Abstract] [Full-text]
45. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.
    Blood, 113(19): 4771-9. [Abstract] [Full-text]
46. Gfi1 regulates miR-21 and miR-196b to control myelopoiesis.
    Blood, 113(19): 4720-8. [Abstract] [Full-text]
47. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.
    Blood, 113(19): 4711-9. [Abstract] [Full-text]
48. Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice.
    J Autoimmun, 32(3): 216-22. [Abstract] [Full-text]
49. Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow.
    Nature, 459(7243): 103-7. [Abstract] [Full-text]
50. Electro-acupuncture promotes survival, differentiation of the bone marrow mesenchymal stem cells as well as functional recovery in the spinal cord-transected rats.
    BMC Neurosci, 10: 35. [Abstract] [Full-text]
51. Gorham's disease of the fibula: a case report.
    J Foot Ankle Surg, 48(3): 347-52. [Abstract] [Full-text]
52. Hurdles to the induction of tolerogenic mixed chimerism.
    Transplantation, 87(9): S79-84. [Abstract] [Full-text]
53. Mechanisms of transplantation tolerance in animals and humans.
    Transplantation, 87(9): S67-9. [Abstract] [Full-text]
54. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells.
    Transplantation, 87(9): S62-6. [Abstract] [Full-text]
55. Mesenchymal stem cells can affect solid organ allograft survival.
    Transplantation, 87(9): S57-62. [Abstract] [Full-text]
56. Mesenchymal stem cells for therapeutic purposes.
    Transplantation, 87(9): S49-53. [Abstract] [Full-text]
57. The immunosuppressive properties of mesenchymal stem cells.
    Transplantation, 87(9): S45-9. [Abstract] [Full-text]
58. Mesenchymal stem cell homing capacity.
    Transplantation, 87(9): S42-5. [Abstract] [Full-text]
59. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase.
    J Am Coll Cardiol, 53(19): 1814-22. [Abstract] [Full-text]
60. Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.
    Blood, 113(19): 4702-10. [Abstract] [Full-text]
61. Elastomeric high-mineral content hydrogel-hydroxyapatite composites for orthopedic applications.
    J Biomed Mater Res A, 89(4): 1098-107. [Abstract] [Full-text]
62. Decontamination of autogenous bone grafts collected during dental implant site preparation: a pilot study.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107(5): 656-60. [Abstract] [Full-text]
63. Peripheral nerve regeneration by transplantation of BMSC-derived Schwann cells as chitosan gel sponge scaffolds.
    J Biomed Mater Res A, 89(4): 1118-24. [Abstract] [Full-text]
64. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect.
    Biomaterials, 30(19): 3271-8. [Abstract] [Full-text]
65. Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing.
    Matrix Biol. [Abstract] [Full-text]
66. Bladder function recovery in rats with traumatic spinal cord injury after transplantation of neuronal-glial restricted precursors or bone marrow stromal cells.
    J Urol, 181(6): 2774-9. [Abstract] [Full-text]
67. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Bone Marrow Transplant. [Abstract] [Full-text]
68. Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan.
    Bone Marrow Transplant. [Abstract] [Full-text]
69. Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment.
    Bone Marrow Transplant. [Abstract] [Full-text]
70. A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
71. Influence of mannose-binding lectin genotypes and serostatus in Allo-SCT: analysis of 131 recipients and donors.
    Bone Marrow Transplant. [Abstract] [Full-text]
72. Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD.
    Bone Marrow Transplant. [Abstract] [Full-text]
73. Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
    Bone Marrow Transplant. [Abstract] [Full-text]
74. EMERGENCY PREPAREDNESS OF RESEARCH CENTER FOR RADIATION MEDICINE AND ITS HOSPITAL TO ADMIT AND TREAT THE PATIENTS WITH SIGNS OF ACUTE RADIATION SICKNESS.
    Radiat Prot Dosimetry. [Abstract] [Full-text]
75. In vivo magnetic resonance tracking of Feridex-labeled bone marrow-derived neural stem cells after autologous transplantation in rhesus monkey.
    J Neurosci Methods, 179(1): 45-50. [Abstract] [Full-text]
76. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis.
    J Hepatol, 50(6): 1174-83. [Abstract] [Full-text]
77. Marrow stromal cell transplantation in stroke and traumatic brain injury.
    Neurosci Lett, 456(3): 120-3. [Abstract] [Full-text]
78. The identification of proteoglycan, collagen and neuron in precursor cells from human fetal spinal cord.
    Neurosci Lett, 457(3): 151-4. [Abstract] [Full-text]
79. Synthesis and evaluation of collagen-chitosan-hydroxyapatite nanocomposites for bone grafting.
    J Biomed Mater Res A, 89(4): 1079-87. [Abstract] [Full-text]
80. Host-derived neoangiogenesis with short-term immunosuppression allows incorporation and remodeling of vascularized diaphyseal allogeneic rabbit femur transplants.
    J Orthop Res, 27(6): 763-70. [Abstract] [Full-text]
81. Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells.
    Stem Cells Dev, 18(4): 591-601. [Abstract] [Full-text]
82. Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction.
    J Cardiovasc Magn Reson, 11(1): 11. [Abstract] [Full-text]
83. Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.
    J Virol, 83(11): 5918-27. [Abstract] [Full-text]
84. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
    Pediatr Hematol Oncol, 26(4): 186-94. [Abstract] [Full-text]
85. Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma.
    Leukemia, 23(5): 961-70. [Abstract] [Full-text]
86. Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study.
    Bone Marrow Transplant, 43(9): 717-23. [Abstract] [Full-text]
87. Bone Structure Changes in Iliac Crest Grafts Combined with Implants.
    Clin Implant Dent Relat Res. [Abstract] [Full-text]
88. Bone Augmentation in Dental Implantology Using Press-Fit Bone Cylinders and Twin-Principle Diamond Hollow Drills: A Case Series.
    Clin Implant Dent Relat Res. [Abstract] [Full-text]
89. Are mesenchymal stromal cells from children resistant to apoptosis?
    Cell Prolif, 42(3): 276-83. [Abstract] [Full-text]
90. Novel sources of fetal stem cells: where do they fit on the developmental continuum?
    Regen Med, 4(3): 423-33. [Abstract] [Full-text]
91. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors.
    Pediatr Blood Cancer, 53(1): 120-4. [Abstract] [Full-text]
92. Airway injury complicating excision of thyroglossal duct cysts.
    Int J Pediatr Otorhinolaryngol, 73(6): 797-801. [Abstract] [Full-text]
93. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Biomaterials, 30(20): 3415-27. [Abstract] [Full-text]
94. Minimally invasive technique for direct repair of pars interarticularis defects in adults using a percutaneous pedicle screw and hook-rod system.
    J Neurosurg Spine, 10(5): 492-5. [Abstract] [Full-text]
95. Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.
    Blood, 113(20): 5002-9. [Abstract] [Full-text]
96. The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy.
    Clin Appl Thromb Hemost, 15(3): 257-62. [Abstract] [Full-text]
97. Persistent retention of colitogenic CD4+ memory T cells causes inflammatory bowel diseases to become intractable.
    Inflamm Bowel Dis, 15(6): 926-34. [Abstract] [Full-text]
98. Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia.
    J Neurooncol, 93(2): 229-32. [Abstract] [Full-text]
99. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects.
    Cell Tissue Res, 336(3): 501-7. [Abstract] [Full-text]
100. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1.
     Arthritis Rheum, 60(5): 1390-405. [Abstract] [Full-text]
101. 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
     Bone Marrow Transplant. [Abstract] [Full-text]
102. Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre.
     Bone Marrow Transplant. [Abstract] [Full-text]
103. The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.
     Bone Marrow Transplant. [Abstract] [Full-text]
104. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia.
     Bone Marrow Transplant. [Abstract] [Full-text]
105. Evaluation of Photocrosslinked Lutrol Hydrogel for Tissue Printing Applications.
     Biomacromolecules. [Abstract] [Full-text]
106. Renal complications in oncologic patients.
     Emerg Med Clin North Am, 27(2): 283-91. [Abstract] [Full-text]
107. Deep-frozen allogeneic onlay bone grafts for reconstruction of atrophic maxillary alveolar ridges: a preliminary study.
     J Oral Maxillofac Surg, 67(6): 1300-6. [Abstract] [Full-text]
108. Intrasocket reactive soft tissue for primary closure after augmentation of extraction sites with severe bone loss before implant placement.
     J Oral Maxillofac Surg, 67(6): 1294-9. [Abstract] [Full-text]
109. Maxillary ridge augmentation with fresh-frozen bone allografts.
     J Oral Maxillofac Surg, 67(6): 1280-5. [Abstract] [Full-text]
110. Intraoperative and perioperative complications in anterior maxillary osteotomy: a retrospective evaluation of 103 patients.
     J Oral Maxillofac Surg, 67(6): 1269-73. [Abstract] [Full-text]
111. Barrier membranes used for ridge augmentation: is there an optimal pore size?
     J Oral Maxillofac Surg, 67(6): 1218-25. [Abstract] [Full-text]
112. Comparison of vascularized osteoperiosteal femur flaps and nonvascularized femur grafts for reconstruction of mandibular defects: an experimental study.
     J Oral Maxillofac Surg, 67(6): 1174-83. [Abstract] [Full-text]
113. New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia.
     J Pediatr, 154(6): 924-30. [Abstract] [Full-text]
114. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.
     J Neuroimmunol, 210(1): 40-51. [Abstract] [Full-text]
115. Comparison of adult neurospheres derived from different origins for treatment of rat spinal cord injury.
     Neurosci Lett, 458(3): 116-21. [Abstract] [Full-text]
116. Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
     Leuk Lymphoma, 50(5): 781-7. [Abstract] [Full-text]
117. Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.
     Clin Cancer Res, 15(10): 3451-61. [Abstract] [Full-text]
118. Feasibility and Tailoring of Bioactive Glass-ceramic Scaffolds with Gradient of Porosity for Bone Grafting.
     J Biomater Appl. [Abstract] [Full-text]
119. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
     Biol Blood Marrow Transplant, 15(6): 679-85. [Abstract] [Full-text]
120. Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.
     Biol Blood Marrow Transplant, 15(6): 662-70. [Abstract] [Full-text]
121. Update on intestinal rehabilitation after intestinal transplantation.
     Curr Opin Organ Transplant, 14(3): 267-73. [Abstract] [Full-text]
122. Reconstructive and ophthalmologic outcomes following resection of spheno-orbital meningiomas.
     Ophthal Plast Reconstr Surg, 25(3): 223-6. [Abstract] [Full-text]
123. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
     JAMA, 301(19): 1997-2004. [Abstract] [Full-text]
124. Hypercostimulation through 4-1BB distorts homeostasis of immune cells.
     J Immunol, 182(11): 6753-62. [Abstract] [Full-text]
125. Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.
     Eur J Pharmacol, 612(1): 87-92. [Abstract] [Full-text]
126. Stem cell therapy for the kidney?
     Am J Ther, 16(3): 247-56. [Abstract] [Full-text]
127. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
     Ann Hematol, 88(7): 667-71. [Abstract] [Full-text]
128. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.
     Stem Cells Dev, 18(5): 773-82. [Abstract] [Full-text]
129. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
     Arterioscler Thromb Vasc Biol, 29(6): 816-22. [Abstract] [Full-text]
130. Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation.
     Proc Natl Acad Sci U S A, 106(20): 8296-301. [Abstract] [Full-text]
131. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
     Cell Immunol, 258(1): 65-71. [Abstract] [Full-text]
132. Selenium and Glutathione Peroxidase Status in Adult Egyptian Patients with Acute Myeloid Leukemia.
     Biol Trace Elem Res. [Abstract] [Full-text]
133. Restoration of gut motility in Kit-deficient mice by bone marrow transplantation.
     J Gastroenterol. [Abstract] [Full-text]
134. Postinjury niches induce temporal shifts in progenitor fates to direct lesion repair after spinal cord injury.
     J Neurosci, 29(20): 6722-33. [Abstract] [Full-text]
135. Multipotent progenitor cells are present in human peripheral blood.
     Circ Res, 104(10): 1225-34. [Abstract] [Full-text]
136. Bone marrow-derived mononuclear cell populations in pediatric and adult patients.
     Cytotherapy. [Abstract] [Full-text]
137. The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSC.
     Cytotherapy. [Abstract] [Full-text]
138. Bone resorption in kidney transplant recipients.
     Transplant Proc, 41(4): 1170-4. [Abstract] [Full-text]
139. Donor-Specific Anti-HLA Antibodies After Bone-Graft Transplantation. Impact on a Subsequent Renal Transplantation: A Case Report.
     Transplant Proc, 41(4): 1138-41. [Abstract] [Full-text]
140. The improvement of ischemia/reperfusion injury by erythropoetin is not mediated through bone marrow cell recruitment in rats.
     Transplant Proc, 41(4): 1113-5. [Abstract] [Full-text]
141. Bone, tendon, and soft tissue reconstruction in one stage with the composite tensor fascia lata flap.
     Ann Plast Surg, 62(6): 665-8. [Abstract] [Full-text]
142. Reconstruction of full-thickness calvarial defect: a role for artificial dermis.
     Ann Plast Surg, 62(6): 656-9. [Abstract] [Full-text]
143. Reconstruction of the cervical trachea using a prefabricated corticoperiosteal flap from the femur.
     Ann Plast Surg, 62(6): 633-6. [Abstract] [Full-text]
144. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.
     Circ Res, 104(10): 1209-16. [Abstract] [Full-text]
145. Modalities and future prospects of gene therapy in heart transplantation.
     Eur J Cardiothorac Surg, 35(6): 1036-44. [Abstract] [Full-text]
146. The influence of three barrier membranes on modeling and incorporation of autologous onlay bone grafts in rats. An evaluation by transversal microradiography.
     Arch Oral Biol, 54(6): 549-55. [Abstract] [Full-text]
147. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.
     Bone Marrow Transplant. [Abstract] [Full-text]
148. Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.
     Bone Marrow Transplant. [Abstract] [Full-text]
149. Acute myelogenous leukemia.
     Exp Hematol, 37(6): 649-58. [Abstract] [Full-text]
150. Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase.
     Am J Pathol, 174(6): 2400-10. [Abstract] [Full-text]
151. Osteomyelitis of the mandible secondary to infantile osteopetrosis: a case report.
     Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107(6): e25-9. [Abstract] [Full-text]
152. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
     Exp Hematol, 37(6): 659-72. [Abstract] [Full-text]
153. Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.
     Biochem Pharmacol, 78(2): 133-41. [Abstract] [Full-text]
154. Persisting NK cell alloreactivity in the presence of long-term stable hematopoietic chimerism.
     Exp Hematol, 37(6): 739-43. [Abstract] [Full-text]
155. Cortical tibial bone graft for nasal augmentation: donor site short scar.
     J Plast Reconstr Aesthet Surg, 62(6): 747-54. [Abstract] [Full-text]
156. Combined use of crushed cartilage and processed fascia lata for dorsal augmentation in rhinoplasty for Asians.
     Laryngoscope, 119(6): 1088-92. [Abstract] [Full-text]
157. Asymptomatic lower extremity deep venous thrombosis resulting in fibula free flap failure.
     Laryngoscope, 119(6): 1085-7. [Abstract] [Full-text]
158. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity.
     Blood, 113(21): 5340-51. [Abstract] [Full-text]
159. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor.
     Vet Res Commun. [Abstract] [Full-text]
160. Hematopoietic stem cell transplantation for pediatric patients with primary immunodeficiency diseases at All Children's Hospital/University of South Florida.
     Immunol Res. [Abstract] [Full-text]
161. FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
     Immunol Res. [Abstract] [Full-text]
162. Osteoclast injection: a promising approach of cell therapy to obtain higher bone union ratio.
     Med Hypotheses, 73(2): 161-2. [Abstract] [Full-text]
163. Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
     Bone Marrow Transplant, 43(10): 793-800. [Abstract] [Full-text]
164. Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT.
     Bone Marrow Transplant, 43(10): 801-6. [Abstract] [Full-text]
165. The effect of composition on ion release from Ca-Sr-Na-Zn-Si glass bone grafts.
     J Mater Sci Mater Med. [Abstract] [Full-text]
166. Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia.
     Blood, 113(22): 5599-604. [Abstract] [Full-text]
167. Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation.
     Blood, 113(22): 5644-9. [Abstract] [Full-text]
168. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.
     Blood, 113(22): 5444-55. [Abstract] [Full-text]
169. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation.
     PLoS One, 4(5): e5643. [Abstract] [Full-text]

© 2004-2010 Bone Grafts Research Today. All Rights Reserved.